Aim immunotech announces first covid-19-induced chronic fatigue “long hauler” patient dosed with ampligen

Aim to host investor conference call on january 12, 2021 at 11am et to discuss developments with amp-511 trial and provide update on other major achievements and upcoming milestones aim to host investor conference call on january 12, 2021 at 11am et to discuss developments with amp-511 trial and provide update on other major achievements and upcoming milestones
AIM Ratings Summary
AIM Quant Ranking